Title |
Cost-effectiveness of a bivalent human papillomavirus vaccination program in Japan
|
---|---|
Published in |
Sexual Health, September 2015
|
DOI | 10.1071/sh14241 |
Pubmed ID | |
Authors |
Luke B. Connelly, Ha N. D. Le |
Abstract |
Background: Human papillomavirus (HPV) vaccines and their widespread adoption have the potential to relieve a large part of the burden of cervical cancer morbidity and mortality, particularly in countries that have low screening rates or, like Japan, lack a cohesive universal screening program. An economic evaluation was conducted to assess the cost-effectiveness of introducing a bivalent HPV vaccination program in Japan from a healthcare perspective. Methods: A Markov model of the natural history of HPV infection that incorporates both vaccination and screening was developed for Japan. The modelled intervention, a bivalent HPV vaccine with a 100% lifetime vaccine efficacy and 80% vaccine coverage, given to a cohort of 12-year-old Japanese girls in conjunction with the current screening program, was compared with screening alone in terms of costs and effectiveness. A discount rate of 5% was applied to both costs and utilities where relevant. Results: Vaccination alongside screening compared with screening alone is associated with an incremental cost-effectiveness ratio (ICER) of US$20 315 per quality-adjusted-life-year gained if 80% coverage is assumed. The ICER at 5% coverage with the vaccine plus screening, compared with screening alone, is US$1158. Conclusion: The cost-effectiveness results suggest that the addition of a HPV vaccination program to Japan's cervical cancer screening program is highly likely to prove a cost-effective way to reduce the burden of cervical cancer, precancerous lesions and HPV16/18-related diseases. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 3% |
Unknown | 39 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 18% |
Student > Ph. D. Student | 5 | 13% |
Student > Master | 5 | 13% |
Student > Postgraduate | 3 | 8% |
Other | 2 | 5% |
Other | 5 | 13% |
Unknown | 13 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 23% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 8% |
Economics, Econometrics and Finance | 3 | 8% |
Social Sciences | 3 | 8% |
Nursing and Health Professions | 2 | 5% |
Other | 5 | 13% |
Unknown | 15 | 38% |